Literature DB >> 26045994

miR-222/VGLL4/YAP-TEAD1 regulatory loop promotes proliferation and invasion of gastric cancer cells.

Nan Li1, Nanrong Yu1, Jia Wang1, Haofeng Xi1, Weiqun Lu1, Houwei Xu1, Min Deng2, Guopei Zheng2, Haiying Liu1.   

Abstract

Gastric cancer (GC) is one of the most common malignant tumors and recent data demonstrates the tumor suppressor role of VGLL4 in GC, but the mechanisms for VGLL4 downregulation in GC remain to be elucidated. Here, we confirmed the suppressor role of VGLL4 on proliferation and invasion in GC cells with over-activated YAP-TEAD signal, and indicated the reverse correlation between expression patters of VGLL4 and miR-222. Bioinformatics analysis combined with experimental confirmation revealed VGLL4 is a direct target of miR-222 in GC cells. Functionally, miR-222 inhibitor significantly inhibited GC cells proliferation and invasion and VGLL4 knockdown abolished the effects of miR-222 inhibitor. Moreover, TEAD1 knockdown resulted in decrease of miR-222 expression and increase of VGLL4 expression, and also resulted in reduction of luciferase activity driven by miR-222 promoter in GC cells, suggesting over-activated TEAD1 positively feedback transcriptionally regulates miR-222 expression via physically binding to the miR-222 promoter indicated by ChIP assay. Collectively, our findings implied the important role of miR-222/VGLL4/YAP-TEAD1 regulatory loop maintaining over-activated YAP-TEAD1 signal in GC cells, and enriched the rationale of VGLL4 in GC based on which a promising therapeutic strategy will be developed.

Entities:  

Keywords:  Gastric cancer; TEAD1; VGLL4; miR-222

Year:  2015        PMID: 26045994      PMCID: PMC4449443     

Source DB:  PubMed          Journal:  Am J Cancer Res        ISSN: 2156-6976            Impact factor:   6.166


  24 in total

1.  Structural and functional similarity between the Vgll1-TEAD and the YAP-TEAD complexes.

Authors:  Ajaybabu V Pobbati; Siew Wee Chan; Ian Lee; Haiwei Song; Wanjin Hong
Journal:  Structure       Date:  2012-05-24       Impact factor: 5.006

Review 2.  Hippo signaling: growth control and beyond.

Authors:  Georg Halder; Randy L Johnson
Journal:  Development       Date:  2011-01       Impact factor: 6.868

3.  A novel partner of Scalloped regulates Hippo signaling via antagonizing Scalloped-Yorkie activity.

Authors:  Tong Guo; Yi Lu; Peixue Li; Meng-Xin Yin; Dekang Lv; Wenjing Zhang; Huizhen Wang; Zhaocai Zhou; Hongbin Ji; Yun Zhao; Lei Zhang
Journal:  Cell Res       Date:  2013-09-03       Impact factor: 25.617

Review 4.  MicroRNAs in cancer: biomarkers, functions and therapy.

Authors:  Josie Hayes; Pier Paolo Peruzzi; Sean Lawler
Journal:  Trends Mol Med       Date:  2014-07-12       Impact factor: 11.951

Review 5.  MicroRNAs in stress signaling and human disease.

Authors:  Joshua T Mendell; Eric N Olson
Journal:  Cell       Date:  2012-03-16       Impact factor: 41.582

6.  The Hippo-YAP pathway in organ size control and tumorigenesis: an updated version.

Authors:  Bin Zhao; Li Li; Qunying Lei; Kun-Liang Guan
Journal:  Genes Dev       Date:  2010-05       Impact factor: 11.361

7.  miR-221/222 overexpession in human glioblastoma increases invasiveness by targeting the protein phosphate PTPμ.

Authors:  C Quintavalle; M Garofalo; C Zanca; G Romano; M Iaboni; M del Basso De Caro; J C Martinez-Montero; M Incoronato; G Nuovo; C M Croce; G Condorelli
Journal:  Oncogene       Date:  2011-07-11       Impact factor: 9.867

8.  YAP1 and VGLL3, encoding two cofactors of TEAD transcription factors, are amplified and overexpressed in a subset of soft tissue sarcomas.

Authors:  Zofia Hélias-Rodzewicz; Gaëlle Pérot; Frédéric Chibon; Céline Ferreira; Pauline Lagarde; Philippe Terrier; Jean-Michel Coindre; Alain Aurias
Journal:  Genes Chromosomes Cancer       Date:  2010-12       Impact factor: 5.006

9.  Sleeping Beauty mutagenesis reveals cooperating mutations and pathways in pancreatic adenocarcinoma.

Authors:  Karen M Mann; Jerrold M Ward; Christopher Chin Kuan Yew; Anne Kovochich; David W Dawson; Michael A Black; Benjamin T Brett; Todd E Sheetz; Adam J Dupuy; David K Chang; Andrew V Biankin; Nicola Waddell; Karin S Kassahn; Sean M Grimmond; Alistair G Rust; David J Adams; Nancy A Jenkins; Neal G Copeland
Journal:  Proc Natl Acad Sci U S A       Date:  2012-03-15       Impact factor: 11.205

10.  The Hippo effector Yorkie controls normal tissue growth by antagonizing scalloped-mediated default repression.

Authors:  Laura M Koontz; Yi Liu-Chittenden; Feng Yin; Yonggang Zheng; Jianzhong Yu; Bo Huang; Qian Chen; Shian Wu; Duojia Pan
Journal:  Dev Cell       Date:  2013-05-28       Impact factor: 12.270

View more
  21 in total

1.  Ubiquitin-specific protease 11 (USP11) functions as a tumor suppressor through deubiquitinating and stabilizing VGLL4 protein.

Authors:  Encheng Zhang; Bing Shen; Xingyu Mu; Yan Qin; Fang Zhang; Yong Liu; Jiantao Xiao; Pingzhao Zhang; Chenji Wang; Mingyue Tan; Yu Fan
Journal:  Am J Cancer Res       Date:  2016-12-01       Impact factor: 6.166

2.  Cyclin-dependent kinase 1 (CDK1)-mediated mitotic phosphorylation of the transcriptional co-repressor Vgll4 inhibits its tumor-suppressing activity.

Authors:  Yongji Zeng; Seth Stauffer; Jiuli Zhou; Xingcheng Chen; Yuanhong Chen; Jixin Dong
Journal:  J Biol Chem       Date:  2017-07-24       Impact factor: 5.157

Review 3.  From vestigial to vestigial-like: the Drosophila gene that has taken wing.

Authors:  Emilie Simon; Corinne Faucheux; Alain Zider; Nadine Thézé; Pierre Thiébaud
Journal:  Dev Genes Evol       Date:  2016-04-26       Impact factor: 0.900

4.  Upregulation of miR-222 in both Helicobacter pylori- infected and noninfected gastric cancer patients.

Authors:  Mina Noormohammad; Samira Sadeghi; Hossein Tabatabaeian; Kamran Ghaedi; Ardeshir Talebi; Mansoureh Azadeh; Mehri Khatami; Mohammad Mehdi Heidari
Journal:  J Genet       Date:  2016-12       Impact factor: 1.166

Review 5.  VGLL4 is a transcriptional cofactor acting as a novel tumor suppressor via interacting with TEADs.

Authors:  Xiaochong Deng; Lin Fang
Journal:  Am J Cancer Res       Date:  2018-06-01       Impact factor: 6.166

6.  The TEA domain family transcription factor TEAD4 represses murine adipogenesis by recruiting the cofactors VGLL4 and CtBP2 into a transcriptional complex.

Authors:  Wenxiang Zhang; Jinjin Xu; Jinhui Li; Tong Guo; Dan Jiang; Xue Feng; Xueyan Ma; Lingli He; Wenqing Wu; Mengxin Yin; Ling Ge; Zuoyun Wang; Margaret S Ho; Yun Zhao; Zhaoliang Fei; Lei Zhang
Journal:  J Biol Chem       Date:  2018-09-12       Impact factor: 5.157

7.  Gastrin-induced miR-222 promotes gastric tumor development by suppressing p27kip1.

Authors:  Katie A Lloyd; Andrew R Moore; Bryony N Parsons; Adrian O'Hara; Malcolm Boyce; Graham J Dockray; Andrea Varro; D Mark Pritchard
Journal:  Oncotarget       Date:  2016-07-19

8.  Nuclear localization of TEF3-1 promotes cell cycle progression and angiogenesis in cancer.

Authors:  Kaixuan Teng; Cuilan Deng; Jie Xu; Qiuxu Men; Tao Lei; Da Di; Ting Liu; Wenhua Li; Xin Liu
Journal:  Oncotarget       Date:  2016-03-22

Review 9.  The TEAD Family and Its Oncogenic Role in Promoting Tumorigenesis.

Authors:  Yuhang Zhou; Tingting Huang; Alfred S L Cheng; Jun Yu; Wei Kang; Ka Fai To
Journal:  Int J Mol Sci       Date:  2016-01-21       Impact factor: 5.923

10.  Naturally existing isoforms of miR-222 have distinct functions.

Authors:  Feng Yu; Katherine A Pillman; Corine T Neilsen; John Toubia; David M Lawrence; Anna Tsykin; Michael P Gantier; David F Callen; Gregory J Goodall; Cameron P Bracken
Journal:  Nucleic Acids Res       Date:  2017-11-02       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.